209 related articles for article (PubMed ID: 29426656)
21. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.
Menzies SL; Kadwad V; Pawloski LC; Lin TL; Baughman AL; Martin M; Tondella ML; Meade BD;
Clin Vaccine Immunol; 2009 Dec; 16(12):1781-8. PubMed ID: 19864485
[TBL] [Abstract][Full Text] [Related]
22. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults.
Litt DJ; Samuel D; Duncan J; Harnden A; George RC; Harrison TG
J Med Microbiol; 2006 Sep; 55(Pt 9):1223-1228. PubMed ID: 16914652
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Commercial Assays for Single-Point Diagnosis of Pertussis in the US.
Pawloski LC; Plikaytis BD; Martin MD; Martin SW; Prince HE; Lapé-Nixon M; Tondella ML
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e15-e21. PubMed ID: 27451419
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal pertussis toxin IgA antibodies in the diagnosis of pertussis in Australian community patients.
Norman D; Karimi M; Herbert A; Beaman MH
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2259-2261. PubMed ID: 28707065
[TBL] [Abstract][Full Text] [Related]
25. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
26. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis.
Xing D; Markey K; Newland P; Rigsby P; Hockley J; He Q
J Immunol Methods; 2011 Sep; 372(1-2):137-45. PubMed ID: 21782823
[TBL] [Abstract][Full Text] [Related]
27. A Novel IgM-capture enzyme-linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis of Bordetella pertussis infection.
Otsuka N; Gotoh K; Nishimura N; Ozaki T; Nakamura Y; Haga K; Yamazaki M; Gondaira F; Okada K; Miyaji Y; Toyoizumi-Ajisaka H; Shibayama K; Arakawa Y; Kamachi K
Microbiol Immunol; 2016 May; 60(5):326-33. PubMed ID: 26996337
[TBL] [Abstract][Full Text] [Related]
28. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.
de Melker HE; Versteegh FG; Conyn-Van Spaendonck MA; Elvers LH; Berbers GA; van Der Zee A; Schellekens JF
J Clin Microbiol; 2000 Feb; 38(2):800-6. PubMed ID: 10655388
[TBL] [Abstract][Full Text] [Related]
29. [Can the determination of IgG antibodies to the pertussis toxin help the diagnosis of the disease?].
Holcíková A; Stroblová H; Jirsenská Z
Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):184-8. PubMed ID: 17080352
[TBL] [Abstract][Full Text] [Related]
30. Serodiagnosis of whooping cough in Belgium: results of the National Reference Centre for Bordetella pertussis anno 2013.
Duterme S; Vanhoof R; Vanderpas J; Pierard D; Huygen K
Acta Clin Belg; 2016 Apr; 71(2):86-91. PubMed ID: 27075799
[TBL] [Abstract][Full Text] [Related]
31. Serodiagnosis as adjunct assay for pertussis infection in São Paulo, Brazil.
Vaz-de-Lima LR; Martin MD; Pawloski LC; Leite D; Rocha KC; de Brito CA; Vaz TM; Martins LM; Alvarenga DP; Ribeiro AF; Carvalhanas TR; Nakasaki RM; Oliveira SS; Waldman EA; Tondella ML;
Clin Vaccine Immunol; 2014 May; 21(5):636-40. PubMed ID: 24599531
[TBL] [Abstract][Full Text] [Related]
32. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.
Dalby T; Sørensen C; Petersen JW; Krogfelt KA
APMIS; 2010 Dec; 118(12):968-72. PubMed ID: 21091778
[TBL] [Abstract][Full Text] [Related]
33. Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels.
Nagel J; de Graaf S; Schijf-Evers D
Dev Biol Stand; 1985; 61():325-30. PubMed ID: 2872120
[TBL] [Abstract][Full Text] [Related]
34. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the usefulness of Bordetella pertussis toxins for serodiagnosis of whooping cough].
Chodorowska M; Kuklińska D
Med Dosw Mikrobiol; 1998; 50(1-2):89-95. PubMed ID: 9857618
[TBL] [Abstract][Full Text] [Related]
36. Characterization of serological responses to pertussis.
Watanabe M; Connelly B; Weiss AA
Clin Vaccine Immunol; 2006 Mar; 13(3):341-8. PubMed ID: 16522775
[TBL] [Abstract][Full Text] [Related]
37. Antibody levels against B. pertussis in neonates measured in dried blood spots.
van Ommen CC; Elvers LH; Notermans DW; van Huisseling JC; Teunis PF; Versteegh FG
Vaccine; 2012 Mar; 30(16):2697-700. PubMed ID: 22227147
[TBL] [Abstract][Full Text] [Related]
38. Pertussis serosurveillance study in Izmir, Turkey.
Türkoglu E; Sönmez C; Kurugöl Z; Çöplü N; Koturoğlu G
J Trop Pediatr; 2015 Feb; 61(1):32-6. PubMed ID: 25424662
[TBL] [Abstract][Full Text] [Related]
39. Laboratory diagnosis of pertussis infections: the role of PCR and serology.
Fry NK; Tzivra O; Li YT; McNiff A; Doshi N; Maple PAC; Crowcroft NS; Miller E; George RC; Harrison TG
J Med Microbiol; 2004 Jun; 53(Pt 6):519-525. PubMed ID: 15150332
[TBL] [Abstract][Full Text] [Related]
40. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.
Riffelmann M; Thiel K; Schmetz J; Wirsing von Koenig CH
J Clin Microbiol; 2010 Dec; 48(12):4459-63. PubMed ID: 20943873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
